HDV RNA assays: Performance characteristics, clinical utility, and challenges

Coinfection with HBV and HDV results in hepatitis D, the most severe form of chronic viral hepatitis, frequently leading to liver decompensation and HCC. Pegylated interferon alpha, the only treatment option for chronic hepatitis D for many years, has limited efficacy. New treatments are in advanced...

Celý popis

Podrobná bibliografie

Vydáno v:	Hepatology (Baltimore, Md.) Ročník 81; číslo 2; s. 637 - 650
Hlavní autoři:	Wedemeyer, Heiner, Leus, Mitchell, Battersby, Thomas R., Glenn, Jeffrey, Gordien, Emmanuel, Kamili, Saleem, Kapoor, Hema, Kessler, Harald H., Lenz, Oliver, Lütgehetmann, Marc, Mixson-Hayden, Tonya, Simon, Christian O., Thomson, Michael, Westman, Gabriel, Miller, Veronica, Terrault, Norah, Lampertico, Pietro
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Lippincott Williams & Wilkins 01.02.2025
Témata:	Antiviral Agents - therapeutic use Coinfection Hepatitis D - diagnosis Hepatitis D - drug therapy Hepatitis D - virology Hepatitis D, Chronic - diagnosis Hepatitis D, Chronic - drug therapy Hepatitis D, Chronic - virology Hepatitis Delta Virus - genetics Hepatitis Delta Virus - isolation & purification Humans Reviews RNA, Viral - analysis
ISSN:	0270-9139, 1527-3350, 1527-3350
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!